Longeveron is a life sciences company developing biological solutions for aging and aging-associated diseases through the use of Allogeneic Human Mesenchymal Stem Cells, harvested and grown at our facility in Miami, Florida, from adult-donor bone marrow. The Longeveron-grown Mesenchymal Stem Cells (LMSCs) are multipotent stem cells.
Stem cell therapy is emerging as the most promising new treatment option for chronic diseases and injuries affecting various organ systems. One of the most exciting ideas emerging from the field of regenerative medicine is the theory that stem cells can treat aging-related disability and frailty, reducing inflammation and improving function capacity and quality of life for human beings. Stem cells have the potential to increase longevity and could ameliorate diseases and disorders associated with aging.
Despite its promise and possible life-saving application, there are no FDA approved stem cell treatments in the United States. Our LMSCs are currently undergoing rigorous testing for FDA approval and are in Stage II of the process, with clinical trials underway. We hope to be the first to offer stem cells as a safe, effective, FDA approved treatment for conditions such as Aging Frailty, Alzheimer’s disease and Metabolic Syndrome.
Longeveron is located in the Life Science & Technology Park (LSTP) in Miami, Florida. Its state-of-the-art manufacturing facilities and production are under FDA oversight and comply with FDA and other regulatory agency requirements. Thus, patients and physicians can be confident that an exceptionally safe and high-quality product is delivered.